Subscribe

Idarucizumab (Praxbind) for Reversal of Dabigatran (Pradaxa)

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Therapy with dabigatran (Pradaxa) can be associated with severe hemorrhage. Idarucizumab (Praxbind) has been approved as an antidote for dabigatran-related bleeding.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone